Dyne Therapeutics, Inc. ($DYN)
Filing Information
| Accession Number | 0001577014-26-000010 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 26, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
267,760
Total Value
$5,646,496.80
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 23, 2026 | Sale | 77,855 | $21.13 | $1,645,076.15 | 4,805,639 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 23, 2026 | Sale | 39,131 | $21.13 | $826,838.03 | 1,510,157 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 23, 2026 | Sale | 30,774 | $21.13 | $650,254.62 | 1,106,036 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 24, 2026 | Sale | 50,530 | $21.02 | $1,062,140.60 | 4,755,109 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 24, 2026 | Sale | 25,397 | $21.02 | $533,844.94 | 1,484,760 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 24, 2026 | Sale | 19,973 | $21.02 | $419,832.46 | 1,086,063 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 25, 2026 | Sale | 12,699 | $21.10 | $267,948.90 | 4,742,410 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 25, 2026 | Sale | 6,382 | $21.10 | $134,660.20 | 1,478,378 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 25, 2026 | Sale | 5,019 | $21.10 | $105,900.90 | 1,081,044 | Indirect | See footnote | View Details |